Zhijun Li

发表

Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer

Shuang-wu Lv, Zhenguo Shi, Xiaohui Wang, 2020, OncoTargets and therapy.

Metformin and oxyphotodynamic therapy as a novel treatment approach for triple-negative breast cancer

Zhijun Li, Jianzhong Xian, Hongjun Jin, 2020, Annals of translational medicine.

Circ_0057553/miR-515-5p Regulates Prostate Cancer Cell Proliferation, Apoptosis, Migration, Invasion and Aerobic Glycolysis by Targeting YES1

Yang Zhang, Zhenguo Shi, Xiaohui Wang, 2020, OncoTargets and therapy.

Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma

Zhijun Li, Shuang-Shuang Dong, Chang-Xue Li, 2022, Disease markers.

NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1

Xiaohui Wang, Pengyi Zheng, Hui-bing Li, 2022, Disease markers.

A non-functional 5′ ALK fusion validated at the RNA level as a classical EML4-ALK that responds well to the novel ALK inhibitor ensartinib: A case report

Hong Yang, Zhijun Li, Jianhua Zhu, 2022, Frontiers in Medicine.

CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2

Zhenguo Shi, Xiaohui Wang, Pengyi Zheng, 2018, Cell cycle.

High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer

Zhenguo Shi, Xiaohui Wang, Pengyi Zheng, 2017, Archives of medical science : AMS.

The Correlation of HK2 Gene Expression with the Occurrence, Immune Cell Infiltration, and Prognosis of Renal Cell Carcinoma

Pengyi Zheng, Hui-bing Li, Zhijun Li, 2022, Disease markers.

Evaluation of [18F]F-TZ3108 for PET Imaging of Metabolic-Associated Fatty Liver Disease

Zhijun Li, Mingxing Huang, Hongjun Jin, 2022, Molecular Imaging and Biology.

The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells

Benyi Li, Zhijun Li, Xiaoqing Zheng, 2009, Journal of experimental & clinical cancer research : CR.

Preclinical Evaluation of [64Cu]NOTA-CP01 as a PET Imaging Agent for Metastatic Esophageal Squamous Cell Carcinoma.

H. Shan, Zhijun Li, Hongjun Jin, 2021, Molecular pharmaceutics.

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma

H. Shan, Zhijun Li, Dan Li, 2021, Annals of translational medicine.

PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer [18F]4A in Mice and Non-human Primates.

H. Liu, Zhijun Li, Hongjun Jin, 2022, ACS chemical neuroscience.

Loss-of-function Mutations K11E or E271K Lead to Novel Tumor Suppression, Implicate Nucleolar Helicase DDX24 Oncogenicity

Zhijun Li, Jianzhong Xian, Hongjun Jin, 2022, International journal of medical sciences.

KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3

Zhenguo Shi, Xiaohui Wang, Pengyi Zheng, 2021, International journal of molecular medicine.

Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [18F]DPA-714 Targeting TSPO.

Zhijun Li, Hongjun Jin, M. Cui, 2023, ACS chemical neuroscience.

C-type lectin 2D (CLEC2D) is upregulated in clear cell renal cell carcinoma (ccRCC) tissues and predicts poor prognosis

Pengyi Zheng, Hui-bing Li, Qingjiang Han, 2024, Heliyon.